JP Patent

JP4151751B2 — 新規ビシクロヌクレオシド類縁体

Assigned to Daiichi Sankyo Co Ltd · Expires 2008-09-17 · 18y expired

What this patent protects

Patent listed against olezarsen-sodium.

Drugs covered by this patent

olezarsen-sodium (OLEZARSEN SODIUM)

Patent Metadata

Patent number: JP4151751B2
Jurisdiction: JP
Classification: —
Expires: 2008-09-17
Drug substance claim: No
Drug product claim: No
Assignee: Daiichi Sankyo Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.